For patients on compounded semaglutide or tirzepatide through TrimRx, your pharmacy label includes contact information and your provider is reachable through the platform
Characteristics of trials and patients are reported, respectively, in Table 1
A daily ODT may be a better fit if needle anxiety is your biggest barrier to starting GLP-1 treatment
If your body weight falls below these BMI measurements, your health provider may recommend a different weight loss intervention, such as a reduced-calorie diet or increased exercise
Friends who had tried the drug pointed out that their loss of interest in food had made them depressed
Key findings from the new studies: ARTIOS trial: Patients who switched to Kesimpta after experiencing relapses or MRI activity on other oral treatments showed fewer relapses, suppressed MRI activity, and over 90% achieved no evidence of disease activity (NEDA-3)